Faro Health

Overview
News
Hospital Management?
Product stageSegments
Go-to-Market
?
Clinical operations and workflow management
?

Faro Health is a company that provides a cloud-based software platform to streamline the design and execution of clinical trials in the life sciences industry. The platform leverages real-world data and insights to help teams collaboratively develop complex clinical protocols that balance scientific needs with operational feasibility, patient centricity, and regulatory requirements.

Faro Health's proprietary platform offers a standardized library of study activities augmented with performance data. It provides intuitive visualizations and real-time insights during protocol development, enabling teams to make informed decisions about the impact of every study activity and associated measurement. This approach ensures protocols are operationally efficient, minimizing burden on patients, sites, payers, and regulators.

Launched in 2019, Faro Health's platform has been adopted by various pharmaceutical and biotechnology companies to author clinical studies efficiently and automate downstream processes through digital data flow. The company's innovative solution addresses the increasing complexity of clinical trials, with the number of endpoints and patient assessments growing significantly over the past decade.

In February 2023, Faro Health raised USD 20 million in a Series A funding round led by General Catalyst, with participation from existing investors Section 32, Polaris Partners, Zetta Ventures, and Northpond Ventures.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
3366 N Torrey Pines Ct Suite 225 La Jolla CA USA
Founded year:
2019
Employees:
11-50
IPO status:
Private
Total funding:
USD 35.0 mn
Last Funding:
USD 20.0 mn (Series A; Feb 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.